{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:00:15Z","timestamp":1764248415702,"version":"3.46.0"},"reference-count":33,"publisher":"Akademiai Kiado Zrt.","issue":"4","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2025,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The 16S rRNA sequencing technology was used to investigate changes in the abundance of intestinal microbiota, metabolites of blood and fecal samples were analyzed and their relationships with neurotransmitters were evaluated in patients with liver cirrhosis after hepatitis B infection. The liver function phenotypes correlated with Phylum Proteobacteria, Class Clostridia and Gamma Proteobacteria, Family Enterobacteriaceae, Ruminococcaceae, Streptococcaceae, Lachnospiraceae and Lactobacillaceae, Genus Faecalibacterium, Streptococcus, species\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    , etc. Genus Streptococcus has a good diagnostic value for patients with liver cirrhosis in the COM (Compensated liver disease) group, with an AUC of 0.81 (95% CI: 0.70\u20130.92), while Genus Streptococcus, Veillonella, Faecalibacterium, Blautia, and Bacteroides have a better diagnostic value for patients with liver cirrhosis in the DECOM (Decompensated liver disease) group (including DECOM1 and DECOM2), with the combined AUC reaching 0.93 (95% CI: 0.88\u20130.98). The level of ammonia in the DECOM2 group was significantly higher than that of the COM group (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.01). Patients with post-hepatitis B cirrhosis have intestinal flora disorder, which leads to abnormal amino acid metabolism and further leads to neurotransmitter disorder in patients with cirrhosis and accelerates the disease progression. Probiotics can reduce the serum ammonia level in patients with cirrhosis and may prevent the occurrence of hepatic encephalopathy.\n                  <\/jats:p>","DOI":"10.1556\/030.2025.02693","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:08Z","timestamp":1761901448000},"page":"313-320","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis"],"prefix":"10.1556","volume":"72","author":[{"given":"Xiaohu","family":"Gao","sequence":"first","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang City, 453000, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keju","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang City, 453000, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7143-8015","authenticated-orcid":true,"given":"Shaoshan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang City, 453000, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"B1","series-title":"Front Immunol","article-title":"Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC","volume":"15","author":"Khan MN","year":"2024","unstructured":"Khan MN, Mao B, Hu J, Shi M, Wang S, Rehman AU, et\u00a0al. Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC. Front Immunol 2024; 15: 1472430."},{"key":"B2","series-title":"J Clin Med","first-page":"4514","article-title":"Autoimmune hepatitis and drug-induced liver injury in Japan","volume":"14","author":"Nishikawa H","year":"2025","unstructured":"Nishikawa H, Kim SK, Asai A. Autoimmune hepatitis and drug-induced liver injury in Japan. J Clin Med 2025; 14: 4514."},{"key":"B3","series-title":"World J Hepatol","first-page":"1210","article-title":"Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990\u20132019","volume":"15","author":"Liu ZP","year":"2023","unstructured":"Liu ZP, Ouyang GQ, Huang GZ, Wei J, Dai L, He SQ, et\u00a0al. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990\u20132019. World J Hepatol 2023; 15: 1210\u20131225."},{"key":"B4","series-title":"Gene Expr","first-page":"105","article-title":"Epidemiological realities of alcoholic liver disease: global burden, research trends, and therapeutic promise","volume":"20","author":"Xiao J","year":"2020","unstructured":"Xiao J, Wang F, Wong NK, Lv Y, Liu Y, Zhong J, et\u00a0al. Epidemiological realities of alcoholic liver disease: global burden, research trends, and therapeutic promise. Gene Expr 2020; 20: 105\u2013118."},{"key":"B5","series-title":"Int J Mol Sci","first-page":"7873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z H","year":"2024","unstructured":"Akk\u0131z H, Gieseler RK, Canbay A. Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells. Int J Mol Sci 2024; 25: 7873."},{"key":"B6","series-title":"Curr Opin Gastroenterol","first-page":"69","article-title":"The gut microbiome in health and in disease","volume":"31","author":"Shreiner AB","year":"2015","unstructured":"Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015; 31: 69\u201375."},{"key":"B7","series-title":"Microorganisms","first-page":"2333","article-title":"Unraveling the role of the human gut microbiome in health and diseases","volume":"12","author":"Khalil M","year":"2024","unstructured":"Khalil M, Di Ciaula A, Mahdi L, Jaber N, Di Palo DM, Graziani A, et\u00a0al. Unraveling the role of the human gut microbiome in health and diseases. Microorganisms 2024; 12: 2333."},{"key":"B8","series-title":"Front Med","article-title":"Liver cirrhosis and complications from the perspective of dysbiosis","volume":"10","author":"Nie G","year":"2024","unstructured":"Nie G, Zhang H, Xie D, Yan J, Li X. Liver cirrhosis and complications from the perspective of dysbiosis. Front Med 2024; 10: 1320015."},{"key":"B9","series-title":"Front Cell Infect Microbiol","article-title":"Gut microbiota targeted approach in the management of chronic liver diseases","volume":"12","author":"Liu J","year":"2022","unstructured":"Liu J, Yang D, Wang X, Asare PT, Zhang Q, Na L, et\u00a0al. Gut microbiota targeted approach in the management of chronic liver diseases. Front Cell Infect Microbiol 2022; 12: 774335."},{"key":"B10","series-title":"Aging Dis","first-page":"1106","article-title":"Functions of gut microbiota metabolites, current status and future perspectives","volume":"13","author":"Liu J","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis 2022; 13: 1106\u20131126."},{"key":"B11","series-title":"Nutrients","first-page":"1474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in Obese patients?","volume":"12","author":"Magne F","year":"2020","unstructured":"Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, et\u00a0al. The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in Obese patients? Nutrients 2020; 12: 1474."},{"key":"B12","series-title":"Int J Mol Sci","first-page":"9588","article-title":"Influence of foods and nutrition on the gut microbiome and implications for intestinal health","volume":"23","author":"Zhang P","year":"2022","unstructured":"Zhang P. Influence of foods and nutrition on the gut microbiome and implications for intestinal health. Int J Mol Sci 2022; 23: 9588."},{"key":"B13","series-title":"Postgrad Med","first-page":"52","article-title":"Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible","volume":"109","author":"Abou-Assi S","year":"2001","unstructured":"Abou-Assi S, Vlahcevic ZR. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible. Postgrad Med 2001; 109: 52\u201354."},{"key":"B14","series-title":"J Nutr","first-page":"1579S","article-title":"Aromatic amino acid metabolism during liver failure","volume":"137","author":"Dejong CH","year":"2007","unstructured":"Dejong CH, van de Poll MCG, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. J Nutr 2007; 137: 1579S\u20131585S."},{"key":"B15","series-title":"Int\u00a0J\u00a0Mol Sci","first-page":"6197","article-title":"The role of amino acids in\u00a0neurotransmission and fluorescent tools for their detection","volume":"21","author":"Dalangin R","year":"2020","unstructured":"Dalangin R, Kim A, Campbell RE. The role of amino acids in\u00a0neurotransmission and fluorescent tools for their detection. Int\u00a0J\u00a0Mol Sci 2020; 21: 6197."},{"key":"B16","series-title":"Sci Data","article-title":"A collection of rumen bacteriome data from 334 mid-lactation dairy cows","volume":"6","author":"Sun HZ","year":"2019","unstructured":"Sun HZ, Xue M, Guan LL, Liu J. A collection of rumen bacteriome data from 334 mid-lactation dairy cows. Sci Data 2019; 6: 180301."},{"key":"B17","series-title":"Bioinformatics","first-page":"2882","article-title":"Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data","volume":"31","author":"A\u00dfhauer KP","year":"2015","unstructured":"A\u00dfhauer KP, Wemheuer B, Daniel R, Meinicke P. Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data. Bioinformatics 2015; 31: 2882\u20132884."},{"key":"B18","series-title":"Nat Rev Microbiol","first-page":"719","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu CL","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol 2023; 21: 719\u2013733."},{"key":"B19","series-title":"Discov Oncol","first-page":"1551","article-title":"AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma","volume":"16","author":"Khan MN","year":"2025","unstructured":"Khan MN, Binli M, Juan H, Mengjia S, Shunyao W, Li X. AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma. Discov Oncol 2025; 16: 1551."},{"key":"B20","series-title":"World J Gastroenterol","first-page":"3010","article-title":"Role of bile acids in liver diseases mediated by the gut microbiome","volume":"27","author":"Shao JW","year":"2021","unstructured":"Shao JW, Ge TT, Chen SZ, Wang G, Yang Q, Huang CH, et\u00a0al. Role of bile acids in liver diseases mediated by the gut microbiome. World J Gastroenterol 2021; 27: 3010\u20133021."},{"key":"B21","series-title":"Front Microbiol","article-title":"Assessment of the safety and probiotic properties of Roseburia intestinalis: a potential \u201cnext generation probiotic\u201d","volume":"13","author":"Zhang C","year":"2022","unstructured":"Zhang C, Ma K, Nie K, Deng M, Luo W, Wu X, et\u00a0al. Assessment of the safety and probiotic properties of Roseburia intestinalis: a potential \u201cnext generation probiotic\u201d. Front Microbiol 2022; 13: 973046."},{"key":"B22","series-title":"Biosci Rep","article-title":"The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis","volume":"43","author":"Zhu R","year":"2023","unstructured":"Zhu R, Liu L, Zhang G, Dong J, Ren Z, Li Z. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis. Biosci Rep 2023; 43: BSR20222524."},{"key":"B23","series-title":"Microorganisms","first-page":"762","article-title":"The effect of amino acids on production of SCFA and bCFA by members of the porcine colonic microbiota","volume":"10","author":"Van den Abbeele P","year":"2022","unstructured":"Van den Abbeele P, Ghyselinck J, Marzorati M, Koch AM, Lambert W, Michiels J, et\u00a0al. The effect of amino acids on production of SCFA and bCFA by members of the porcine colonic microbiota. Microorganisms 2022; 10: 762."},{"key":"B24","series-title":"Front Microbiol","first-page":"973","article-title":"An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors","volume":"11","author":"Rios-Covian D","year":"2020","unstructured":"Rios-Covian D, Gonz\u00e1lez S, Nogacka AM, Arboleya S, Salazar N, Gueimonde M, et\u00a0al. An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors. Front Microbiol 2020; 11: 973."},{"key":"B25","series-title":"J Clin Exp Hepatol","first-page":"S29","article-title":"Gut microbiota: its role in hepatic encephalopathy","volume":"5","author":"Rai R","year":"2015","unstructured":"Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol 2015; 5: S29\u2013S36."},{"key":"B26","series-title":"Physiology (Bethesda)","first-page":"261","article-title":"Gut microbiota in liver disease: what do we know and what do we not know?","volume":"35","author":"Jiang L","year":"2020","unstructured":"Jiang L, Schnabl B. Gut microbiota in liver disease: what do we know and what do we not know? Physiology (Bethesda) 2020; 35: 261\u2013274."},{"key":"B27","series-title":"J Hepatol","first-page":"1526","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose CF","year":"2020","unstructured":"Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et\u00a0al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol 2020; 73: 1526\u20131547."},{"key":"B28","series-title":"J Hosp Med","first-page":"S8","article-title":"Inadequate practices for hepatic encephalopathy management in the inpatient setting","volume":"17","author":"Shaw J","year":"2022","unstructured":"Shaw J, Beyers L, Bajaj JS. Inadequate practices for hepatic encephalopathy management in the inpatient setting. J Hosp Med 2022; 17: S8\u2013S16."},{"key":"B29","series-title":"World J Hepatol","first-page":"50","article-title":"Hepatic encephalopathy: an approach to its multiple pathophysiological features","volume":"4","author":"Perazzo JC","year":"2012","unstructured":"Perazzo JC, Tallis S, Delfante A, Souto PA, Lemberg A, Eizayaga FX, et\u00a0al. Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepatol 2012; 4: 50\u201365."},{"key":"B30","series-title":"Biomed Pharmacother","article-title":"Neurotransmitters: impressive regulators of tumor progression","volume":"176","author":"Yang Y","year":"2024","unstructured":"Yang Y, Sun L, Liu X, Liu W, Zhang Z, Zhou X, et\u00a0al. Neurotransmitters: impressive regulators of tumor progression. Biomed Pharmacother 2024; 176: 116844."},{"key":"B31","series-title":"Immune Netw","first-page":"e10","article-title":"Aromatic amino acid metabolites: molecular messengers bridging immune-microbiota communication","volume":"20","author":"Shin HK","year":"2025","unstructured":"Shin HK, Bang YJ. Aromatic amino acid metabolites: molecular messengers bridging immune-microbiota communication. Immune Netw 2025; 20: e10."},{"key":"B32","series-title":"Nutrients","first-page":"449","article-title":"Beneficial effects of probiotic and food borne yeasts on human health","volume":"2","author":"Moslehi-Jenabian S","year":"2010","unstructured":"Moslehi-Jenabian S, Pedersen LL, Jespersen L. Beneficial effects of probiotic and food borne yeasts on human health. Nutrients 2010; 2: 449\u2013473."},{"issue":"1","key":"bib33","series-title":"Discov Oncol 2730-6011","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s12672-025-03017-w","article-title":"AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma","volume":"16","author":"Khan MN","year":"2025","unstructured":"Khan MN, Binli M, Juan H, Mengjia S, Shunyao W, Li X. AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma. Discov Oncol 2730-6011 2025; 16(1): 1551. 10.1007\/s12672-025-03017-w10.1007\/s12672-025-03017-w. 40813509."}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/4\/article-p313.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/4\/article-p313.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/4\/article-p313.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:59:09Z","timestamp":1764248349000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/4\/article-p313.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1556\/030.2025.02693","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"type":"print","value":"1217-8950"},{"type":"electronic","value":"1588-2640"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}